Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Kidney International
|
August 12, 2011
Uncertain etiologies of proteinuric-chronic kidney disease in rural Sri Lanka
Nimmi T C Athuraliya, Tilak D J Abeysekera, Priyanie H Amerasinghe, et al.
Nutrients
|
October 23, 2021
Effect of Omega-3 Supplementation on Self-Regulation in Typically Developing Preschool-Aged Children: Results of the Omega Kid Pilot Study-A Randomised, Double-Blind, Placebo-Controlled Trial
Lauren A Roach, Mitchell K Byrne, Steven J Howard, et al.
Breast Cancer Research and Treatment
|
June 19, 2010
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study
Janine L Mansi, Ann Yellowlees, Julian Lipscombe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2005
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study
T R Jeffry Evans, Ann Yellowlees, Elizabeth Foster, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Kidney International
|
August 12, 2011
Uncertain etiologies of proteinuric-chronic kidney disease in rural Sri Lanka
Nimmi T C Athuraliya, Tilak D J Abeysekera, Priyanie H Amerasinghe, et al.
Nutrients
|
October 23, 2021
Effect of Omega-3 Supplementation on Self-Regulation in Typically Developing Preschool-Aged Children: Results of the Omega Kid Pilot Study-A Randomised, Double-Blind, Placebo-Controlled Trial
Lauren A Roach, Mitchell K Byrne, Steven J Howard, et al.
Breast Cancer Research and Treatment
|
June 19, 2010
Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study
Janine L Mansi, Ann Yellowlees, Julian Lipscombe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 30, 2005
Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study
T R Jeffry Evans, Ann Yellowlees, Elizabeth Foster, et al.
Page
of 5